[1]
M. S. Baig, M. R. Kale, and A. Lamb, “A prospective observational pharmacovigilance study of adverse drug reaction monitoring in patients of MDR-TB at tertiary care hospital”, Int J Basic Clin Pharmacol, vol. 7, no. 7, pp. 1291–1296, Jun. 2018.